Drug Shortage Report for MINT-LOSARTAN/HCTZ

Last updated on 2020-01-27 History
Report ID 74450
Drug Identification Number 02389657
Brand name MINT-LOSARTAN/HCTZ
Common or Proper name losartan/HCTZ
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 count bottles
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-04
Estimated end date 2019-12-31
Actual end date 2020-01-24
Shortage status Resolved
Updated date 2020-01-27
Company comments
Health Canada comments
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-01-27 English Compare
v14 2019-10-21 French Compare
v13 2019-10-21 English Compare
v12 2019-07-04 French Compare
v11 2019-07-04 English Compare
v10 2019-04-08 French Compare
v9 2019-04-08 English Compare
v8 2019-04-08 French Compare
v7 2019-04-08 English Compare
v6 2019-04-08 English Compare
v5 2019-02-28 French Compare
v4 2019-02-28 English Compare
v3 2019-02-05 English Compare
v2 2019-02-04 French Compare
v1 2019-02-04 English Compare